Dr. Pourfarzad presents data on the use of HUB Organoids as advanced modes to investigate ADME and safety.
Poster 553: HUB Organoids™ improve preclinical toxicology, metabolism, and pharmacokinetic studies for drug discovery and development.
Join our Newsletter
and never miss an update!
Want to learn more
about our services?
Drug Screening
Explore how patient-derived HUB Organoids can fast-track your clinical candidate selection
Model and assay development
Decipher the complexity of human disease with our custom development services
